• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Oncolytics Biotech Inc (NQ: ONCY )

    1.070 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Oncolytics Biotech Inc

    < Previous 1 2 Next >
    Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer
    Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer 
    Via News Direct
    ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q1 2024
    ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q4 2023
    ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Recap: Oncolytics Biotech Q4 Earnings
    Via Benzinga
    Oncolytics Biotech's Earnings Outlook
    Via Benzinga
    3 Under-$20 Stocks to Buy for Explosive Returns
    Are you looking to invest in stocks with massive potential? Here are three under $20 stocks to buy for explosive returns. 
    Via InvestorPlace
    Oncolytics Biotech's Earnings: A Preview
    Via Benzinga
    5 Analysts Have This to Say About Oncolytics Biotech
    Via Benzinga
    Expert Ratings for Oncolytics Biotech
    Via Benzinga
    Oncolytics Biotech: Q1 Earnings Insights
    Via Benzinga
    Earnings Scheduled For March 7, 2024
    Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
    Via Benzinga
    A Preview Of Oncolytics Biotech's Earnings
    Via Benzinga
    Earnings Scheduled For November 3, 2023
    Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
    Via Benzinga
    Earnings Scheduled For August 14, 2023
    Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
    Via Benzinga
    Oncolytics Biotech's Earnings: A Preview
    Via Benzinga
    Oncolytics Biotech's Earnings: A Preview
    Via Benzinga
    Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
    Via Benzinga
    Earnings Scheduled For March 3, 2023
    Companies Reporting Before The Bell • Hibbett (NASDAQ:HIBB) is projected to report quarterly earnings at $2.99 per share on revenue of $479.64 million. 
    Via Benzinga
    Earnings Scheduled For August 11, 2022
    Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
    Via Benzinga
    Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. 
    Via Benzinga
    Nasdaq Turns Lower; Dow Tumbles Over 300 Points
    U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 300 points on Thursday. 
    Via Benzinga
    Recap: Oncolytics Biotech Q3 Earnings
    Oncolytics Biotech (NASDAQ:ONCY) reported its Q3 earnings results on Monday, November 7, 2022 at 08:03 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Earnings Scheduled For May 5, 2023
    Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion. 
    Via Benzinga
    Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
    Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250. 
    Via Benzinga
    Oncolytics Reports Partnering With Biopharma Industry Leaders To Fast-Track Immunotherapy Treatment
    This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
    Via Benzinga
    Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
    Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. 
    Via Benzinga
    Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    A Preview Of Oncolytics Biotech's Earnings
    Oncolytics Biotech (NASDAQ:ONCY) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
    Upgrades 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.